Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ALEMBIC   TEVA PHARMA
EQUITY SHARE DATA
    ALEMBIC
Mar-23
TEVA PHARMA
Dec-13
ALEMBIC/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs873,459-   
Low Rs563,005-   
Sales per share (Unadj.) Rs5.01,985.4-  
Earnings per share (Unadj.) Rs3.1124.0-  
Cash flow per share (Unadj.) Rs3.4284.5-  
Dividends per share (Unadj.) Rs2.20108.57-  
Avg Dividend yield %3.13.4 91.9%  
Book value per share (Unadj.) Rs80.92,205.4-  
Shares outstanding (eoy) m256.78848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x14.41.6 883.3%   
Avg P/E ratio x22.726.1 87.1%  
P/CF ratio (eoy) x21.011.4 184.4%  
Price / Book Value ratio x0.91.5 60.1%  
Dividend payout %70.187.5 80.0%   
Avg Mkt Cap Rs m18,2982,741,007 0.7%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m2400-   
Avg. sales/employee Rs Th037,459.7-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,340.1-  
INCOME DATA
Net Sales Rs m1,2721,683,624 0.1%  
Other income Rs m6430-   
Total revenues Rs m1,9151,683,624 0.1%   
Gross profit Rs m297461,061 0.1%  
Depreciation Rs m67136,089 0.0%   
Interest Rs m533,069 0.0%   
Profit before tax Rs m868291,903 0.3%   
Minority Interest Rs m01,326 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-191,619 -0.0%   
Tax Rs m62-3,564 -1.7%   
Profit after tax Rs m806105,175 0.8%  
Gross profit margin %23.427.4 85.3%  
Effective tax rate %7.1-1.2 -583.1%   
Net profit margin %63.46.2 1,014.2%  
BALANCE SHEET DATA
Current assets Rs m1,7211,137,114 0.2%   
Current liabilities Rs m838991,659 0.1%   
Net working cap to sales %69.48.6 803.5%  
Current ratio x2.11.1 179.1%  
Inventory Days Days5,03891 5,549.4%  
Debtors Days Days67396 701.4%  
Net fixed assets Rs m20,324549,909 3.7%   
Share capital Rs m5144,144 12.4%   
"Free" reserves Rs m20,2670-   
Net worth Rs m20,7801,870,187 1.1%   
Long term debt Rs m0860,875 0.0%   
Total assets Rs m22,0463,847,621 0.6%  
Interest coverage x187.79.8 1,909.6%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.10.4 13.2%   
Return on assets %3.73.6 102.4%  
Return on equity %3.95.6 69.0%  
Return on capital %4.24.9 85.2%  
Exports to sales %1.20-   
Imports to sales %2.40-   
Net fx Rs m-140-   
CASH FLOW
From Operations Rs m389268,283 0.1%  
From Investments Rs m73-95,063 -0.1%  
From Financial Activity Rs m-464-321,823 0.1%  
Net Cashflow Rs m-2-148,604 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 82.88 Rs / USD

Compare ALEMBIC With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ALEMBIC With: SANJIVANI PA  NORRIS MEDICINES  IND. SWIFT  WANBURY  TTK HEALTHCARE  



Today's Market

Sensex Today Tanks 735 Points | IT & FMCG Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Tanks 735 Points | IT & FMCG Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets continued the downtrend as the session progressed and ended the day weak.